APA (7th ed.) Citation

CP, C., SP, C., GA, F., H, K., A, K., JA, B., . . . Reicin, A. S. (2006). Cardiovascular outcomes with etoricoxib and diclofenac in patients with osteoarthritis and rheumatoid arthritis in the Multinational Etoricoxib and Diclofenac Arthritis Long-term (MEDAL) programme: A randomised comparison. Lancet, 368(9549), 1771. https://doi.org/10.1016/s0140-6736(06)69666-9

Chicago Style (17th ed.) Citation

CP, Cannon, et al. "Cardiovascular Outcomes with Etoricoxib and Diclofenac in Patients with Osteoarthritis and Rheumatoid Arthritis in the Multinational Etoricoxib and Diclofenac Arthritis Long-term (MEDAL) Programme: A Randomised Comparison." Lancet 368, no. 9549 (2006): 1771. https://doi.org/10.1016/s0140-6736(06)69666-9.

MLA (9th ed.) Citation

CP, Cannon, et al. "Cardiovascular Outcomes with Etoricoxib and Diclofenac in Patients with Osteoarthritis and Rheumatoid Arthritis in the Multinational Etoricoxib and Diclofenac Arthritis Long-term (MEDAL) Programme: A Randomised Comparison." Lancet, vol. 368, no. 9549, 2006, p. 1771, https://doi.org/10.1016/s0140-6736(06)69666-9.